SeaStar Medical Holding Corporation (ICU)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$3.59

-0.26 (-6.75%)

Market Cap: $18.89M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

57%(8/14)

Avg Surprise

-36.86%

Streak

1 Q

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-0.95

Range$-0.95 - $-0.95

1 analysts

EPS RevisionsNo revisions (7d)

30d

EPS Estimate DriftChange to current

90d ago$-0.90-6.1%

60d ago$-0.90-6.1%

30d ago$-0.90-6.1%

7d ago$-0.90-6.1%

Current$-0.95

Revenue Consensus

$500000

Range$500000 - $500000

1 analysts

Period ending Dec 31, 2026

EPS Consensus$-0.92

Range$-0.92 - $-0.92

1 analysts

Revenue Consensus

$576000

Range$576000 - $576000

1 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-0.92	$-0.92 - $-0.92	-	-	1	-	-
Sep 30, 2026Sep 26EST	-	$-0.95	$-0.95 - $-0.95	-	-	1	0 2 30d	-
Jun 30, 2026Jun 26 Reported Aug 12, 2026Reported Aug 12	$-0.91	$-0.91	$-1.03 - $-0.91	+0.00%	Beat	2	0 2 30d	+49.4%
Mar 31, 2026Mar 26 Reported May 13, 2026Reported May 13	$-0.90	$-0.82	$-0.92 - $-0.73	-9.76%	Miss	2	1 0 30d	+79.5%
Dec 31, 2025Dec 25 Reported Mar 25, 2026Reported Mar 25	$-0.80	$-1.01	$-1.06 - $-0.97	+21.18%	Beat	2	1 0 30d	+11.1%
Sep 30, 2025Sep 25 Reported Nov 13, 2025Reported Nov 13	$-1.30	$-1.50	$-1.50 - $-1.50	+13.33%	Beat	1	1 0 30d	+88.2%
Jun 30, 2025Jun 25 Reported Aug 13, 2025Reported Aug 13	$-1.80	N/A	-	+58.14%	Beat	1	0 1 30d	+82.5%
Mar 31, 2025Mar 25 Reported May 14, 2025Reported May 14	$-4.40	$-5.20	$-5.20 - $-5.20	+15.38%	Beat	0	No revisions (30d)	+90.7%
Dec 31, 2024Dec 24 Reported Mar 27, 2025Reported Mar 27	$-0.90	$-0.18	$-0.18 - $-0.18	-400.00%	Miss	0	No revisions (30d)	-309.1%
Sep 30, 2024Sep 24 Reported Nov 13, 2024Reported Nov 13	$-11.00	$-11.30	$-11.30 - $-11.30	+2.65%	Beat	1	No revisions (30d)	+88.1%
Jun 30, 2024Jun 24 Reported Aug 13, 2024Reported Aug 13	$-10.30	$-14.10	$-14.10 - $-14.10	+26.95%	Beat	1	1 0 30d	+83.5%
Mar 31, 2024Mar 24 Reported May 14, 2024Reported May 14	$-47.50	$-37.50	$-37.50 - $-37.50	-26.67%	Miss	1	No revisions (30d)	+52.5%
Dec 31, 2023Dec 23 Reported Mar 13, 2024Reported Mar 13	$-0.22	$-0.13	$-0.13 - $-0.13	-69.23%	Miss	1	No revisions (30d)	+89.2%
Sep 30, 2023Sep 23 Reported Nov 14, 2023Reported Nov 14	$-92.50	$-62.50	$-62.50 - $-62.50	-48.00%	Miss	1	No revisions (30d)	-184900.0%
Jun 30, 2023Jun 23 Reported Aug 14, 2023Reported Aug 14	$-62.50	$-62.50	$-62.50 - $-62.50	+0.00%	Beat	1	No revisions (30d)	-446528.6%
Mar 31, 2023Mar 23 Reported May 15, 2023Reported May 15	$-100.00	$-50.00	-	-100.00%	Miss	-	-	-1000100.0%
Dec 31, 2022Dec 22 Reported Mar 30, 2023Reported Mar 30	$-2.04	N/A	-	N/A	Beat	-	-	-192.3%
Sep 30, 2022Sep 22 Reported Nov 14, 2022Reported Nov 14	$-0.05	N/A	-	N/A	Beat	-	-	-350.0%
Jun 30, 2022Jun 22 Reported Aug 16, 2022Reported Aug 16	$0.01	N/A	-	N/A	Beat	-	-	+109.3%
Mar 31, 2022Mar 22 Reported Apr 6, 2022Reported Apr 6	$0.01	N/A	-	N/A	Beat	-	-	-94.4%
Dec 31, 2021Dec 21 Reported Mar 31, 2022Reported Mar 31	$2.22	N/A	-	N/A	Beat	-	-	-
Sep 30, 2021Sep 21 Reported Nov 17, 2021Reported Nov 17	$0.02	N/A	-	N/A	Beat	-	-	-
Jun 30, 2021Jun 21 Reported Aug 16, 2021Reported Aug 16	$-0.15	N/A	-	N/A	Beat	-	-	-
Mar 31, 2021Mar 21 Reported May 24, 2021Reported May 24	$0.18	N/A	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-0.92	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	-616.00%
ROE	-356.90%	ROIC	-315.82%
Financial Health
Debt/Equity	0.03x	Interest Coverage	N/A
Current Ratio	1.89x	Quick Ratio	1.87x
Trading Statistics
Beta	-1.07	Avg Volume	177.84K
52-Week High	$7.35	52-Week Low	$2.07

Technical Indicators Dashboard

Moving Averages

SMA 10$3.74

SMA 20$3.60

SMA 50$3.34

SMA 200$3.31

EMA 10$3.65

EMA 20$3.57

EMA 50$3.49

EMA 200$3.99

MACD

Line: 0.10Signal: 0.11Hist: -0.01

ADX

ADX: 25.0+DI: 28.5-DI: 13.0

Aroon & PSAR

Aroon Up72.0

Aroon DownN/A

PSAR$4.34

Bollinger Bands

Upper Band$4.24

Lower Band$2.95

%B Position3589%(Upper)

Band Width0.49

RSI (14-Day)

Neutral

50.9

Momentum Oscillators

Stoch %K36.2

Stoch %D34.1

Williams %R-69.1

ROC (10d)0.8%

Momentum0.03

CCI (20d)43.1

MFI (14d)71.8

Volatility Measures

ATR (14d)$0.41(11.3%)

StdDev (20d)0.32

Hist Vol165.2%(High)

Volume Flow

VWAP$3.67

OBV287.9M

AD Line66.6B

CMF (20d)0.386

Volume Metrics

Avg Vol (20d)193.6K

Vol Ratio0.6x

VWMA (20d)$3.75

Pivot Points

R3$4.47

R2$4.21

R1$4.03

Pivot Point$3.77

S1$3.59

S2$3.33

S3$3.15

Advanced Oscillators

TSI6.86

Ultimate Osc49.4

KST162.51

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$615,000	$495,000	$420,000	$183,000	$338,000	$293,000	$67,000	$68,000	$0	$0	$0	$0
Cost of Revenue	$54,000	$46,000	$12,000	$14,000	$27,000	$0	$0	$0	$0	$0	N/A	$0
Gross Profit	$561,000	$449,000	$408,000	$169,000	$311,000	$293,000	$67,000	$68,000	$0	$0	N/A	$0

Operating Expenses	$4.35M	$4.05M	$3.43M	$3.75M	$2.07M	$4.12M	$4.83M	$4.52M	$4.67M	$3.95M	$2.94M	$2.94M
R&D	$2.52M	$2.34M	$2.20M	$1.85M	$1.04M	$2.43M	$2.74M	$2.34M	$2.33M	$1.70M	$1.18M	$1.09M
SG&A	$1.83M	$1.71M	$1.23M	$1.90M	$1.03M	$1.68M	$2.10M	$2.19M	$2.33M	$2.25M	$1.76M	$1.85M
Operating Income	$-3,791,000	$-3,603,000	$-3,018,000	$-3,579,000	$-1,756,000	$-3,822,000	$-4,767,000	$-4,456,000	$-4,669,000	$-3,950,000	$-2,937,000	$-2,942,000

Interest Income	$69,000	$91,000	$125,000	$107,000	$45,000	$48,000	$18,000	$58,000	$25,000	$0	$0	$0
Interest Expense	$8,000	$6,000	$11,000	$0	$9,000	$11,000	$-253,000	$272,000	$82,000	$143,000	$199,000	$5.17M
Income Before Tax	$-3,730,000	$-3,518,000	$-2,904,000	$-3,472,000	$-2,002,000	$-3,769,000	$-4,419,000	$-4,478,000	$-3,233,000	$-12,697,000	$-9,462,000	$-7,232,000
Income Tax Expense	$0	$3,000	$0	$0	$0	$3,000	$0	$0	$3,000	$0	$-5,000	$0

Net Income	$-3,730,000	$-3,521,000	$-2,904,000	$-3,472,000	$-2,002,000	$-3,772,000	$-4,419,000	$-4,478,000	$-3,236,000	$-12,697,000	$-9,457,000	$-7,232,000

EBITDA	$-3,783,000	$-3,597,000	$-3,018,000	$-3,579,000	$-2,031,000	$-3,795,000	$-4,690,000	$-4,219,000	$-3,146,000	$-12,527,000	$-9,252,000	$-2,045,000
EBIT	$-3,791,000	$-3,603,000	$-3,018,000	$-3,579,000	$-2,038,000	$-3,806,000	$-4,690,000	$-4,264,000	$-3,176,000	$-12,554,000	$-9,263,000	$-2,059,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about ICU

News

SeaStar Medical CMO receives combat nephrology award

SeaStar Medical Holding Corporation's Chief Medical Officer, Col. (Ret.) Kevin Chung, has been awarded the 2026 Combat Nephrology Award for his contributions to renal support in trauma and combat casualty environments....

Investing.com•Oct 14, 2026 10:40 AM ET10/14/26•Bullish

A retired military doctor is honored for kidney care in combat

SeaStar Medical's Chief Medical Officer, Col. (Ret.) Kevin Chung, MD, has been named the 2026 recipient of the Combat Nephrology Award. This award recognizes his significant contributions to kidney support in combat...

Stock Titan•Oct 14, 2026 8:41 AM ET10/14/26•Somewhat-Bullish

SeaStar Medical Holding Corporation announced that it has received $3.301572 million in funding

SeaStar Medical Holding Corporation announced that it has successfully closed a funding round, securing $3.301572 million. The transaction, completed on October 8, 2026...

www.marketscreener.com•Oct 8, 2026 10:58 PM ET10/8/26•Bullish

Warrants for up to 59,780 shares accompany SeaStar Medical (ICU)'s capital raise.

SeaStar Medical Holding Corp. (ICU) has successfully raised $3.3 million through a Rule 506(b) exempt offering, with the first sale reported on October 5, 2026. As part of this capital raise...

Stock Titan•Oct 8, 2026 1:13 PM ET10/8/26•Neutral

SeaStar Medical Receives FDA Breakthrough Device Designation for SCD Therapy in Adult Sepsis and Septic Conditions

SeaStar Medical announced that its Selective Cytopheretic Device (SCD) therapy has received FDA Breakthrough Device Designation for treating hyperinflammation in adult sepsis patients. This is the seventh such...

Quiver Quantitative•Oct 7, 2026 9:13 AM ET10/7/26•Bullish

ICU Valuation and Fair Value

P/E: -0.9x
P/B: 3.4x

See GNG's fair value

ICU Profitability: Margins, ROIC and FCF

Gross margin: 92.6%
Operating margin: -616.0%
Net margin: 0.0%
ROIC: -315.8%
ROE: -356.9%
FCF margin: -799.4%

ICU Competitors

Company	Ticker
Entero Therapeutics, Inc.	ENTO
Modular Medical Inc	MODD
Vyne Therapeutics Inc	VYNE
Akari Therapeutics PLC	AKTX
Quoin Pharmaceuticals Ltd DRC	QNRX
Sensei Biotherapeutics Inc	SNSE
Scilex Holding Company	SCLX
Retractable Technologies Inc	RVP

Sector: Healthcare

ICU Bull Case vs Bear Case

Bull case

ICU grew quarterly revenue 82.0% year over year.

ICU Earnings: Beat Rate and Next Report

Beat rate: 5 of 8 quarters (62.5%)
Average surprise: -37.4%
EPS estimate (fiscal period ending Sep 30, 2026): $-0.95
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 0 up, 2 down

Frequently Asked Questions About ICU

Does ICU pay dividends?

SeaStar Medical Holding Corporation (ICU) does not currently pay a regular dividend.

What is ICU's market cap?

SeaStar Medical Holding Corporation (ICU) has a market capitalization of $18.89M with a current stock price of $3.59.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In

Earnings

Performance (10Y)

Upcoming Estimates

Key Metrics

Technical Indicators Dashboard

Moving Averages

MACD

ADX

Aroon & PSAR

Bollinger Bands

RSI (14-Day)

Momentum Oscillators

Volatility Measures

Volume Flow

Volume Metrics

Pivot Points

Advanced Oscillators

Financial Data

Related GNG Research

News

SeaStar Medical CMO receives combat nephrology award

A retired military doctor is honored for kidney care in combat

SeaStar Medical Holding Corporation announced that it has received $3.301572 million in funding

Warrants for up to 59,780 shares accompany SeaStar Medical (ICU)'s capital raise.

SeaStar Medical Receives FDA Breakthrough Device Designation for SCD Therapy in Adult Sepsis and Septic Conditions

ICU Valuation and Fair Value

ICU Profitability: Margins, ROIC and FCF

ICU Competitors

ICU Bull Case vs Bear Case

Bull case

ICU Earnings: Beat Rate and Next Report

Frequently Asked Questions About ICU

Related stocks

Get full access to GNG Research